TherapeuticsMD, Inc.

Regulatory Filings • Mar 26, 2008

NT 10-K 1 c32682nt10k.htm

| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION
OF LATE FILING | |
| --- | --- |
| OMB Number: Expires: | 3235-0058 April 30, 2009 |
| Estimated average
burden hours per response......2.50 | |
| SEC FILE NUMBER | |
| CUSIP NUMBER | |

(Check One): ý Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR

For Period Ended: December 31, 2007 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transition Period Ended: _______

Read Instruction (on back page) Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Croff Enterprises, Inc

Full Name of Registrant

N/A

Former Name if Applicable

3773 Cherry Creek Drive Nort h, Suite 1025

Address of Principle Executive Office (Street and Number )

Denver, CO 80209

City, State and Zip Code

PART II - RULES 12B-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

| ý | The reason described in reasonable detail in Part
III of this form could not be eliminated without unreasonable effort
or expense; |
| --- | --- |
| (b) | The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR,
or Form N-CSR, or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q or subject distribution
report on Form 10-D, or portion
thereof, will be filed on or before the fifth calendar day following
the prescribed due date; and |
| (c) | The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached if applicable. |

PART III - NARRATIVE

State below in reasonable detail why forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Registrant divided the Company in December, 2007, transferring all of its' oil and gas assets to a new private corporation owned by its former Preferred B shareholders. The chief accounting officer resigned in January, 2008, and this 10-K will be substantially different than previous years resulting in the need for additional time to complete it.

(Attach extra Sheets if Needed) PART IV - OTHER INFORMATION

| (1) | Name and telephone number of person to
contact in regard to this notification — Gerald Jensen | (303) | 383-1555 |
| --- | --- | --- | --- |
| | (Name) | (Area Code) | (Telephone Number) |
| (2) | Have all other periodic reports required
under Section 13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the registrant
was required to file such report(s) been filed? If the answer is no,
identify report(s). Yes ý No o | | |
| (3) | Is it anticipated that any significant
change in results of operations from the corresponding period for
the last fiscal year will be reflected by the earnings statements to
be included in the subject report or portion thereof? | | |
| Yes o No ý | | | |
| | If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made. | | |

Croff Enterprises , Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date March 26, 2008 By /s/ Gerald L. Jensen

INSTRUCTION: The form may be signed by an executive officer or the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.